Skip to main content

Advertisement

SpringerLink
Log in

Carfilzomib-related glomerular and tubular injury in a patient with Multiple Myeloma

  • Lessons for the Clinical Nephrologist
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, Niesvizky R, Giralt S, Fermand JP, Blade J, Comenzo RL, Sezer O, Palumbo A, Harousseau JL, Richardson PG, Barlogie B, Anderson KC, Sonneveld P, Tosi P, Cavo M, Rajkumar SV, Durie BG, San Miguel J (2010) Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 28(33):4976–4984

    Article  Google Scholar 

  2. Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG (2010) Presentation and survival of patients with severe acute kidney injury and multiple myeloma: A 20-year experience from a single centre. Nephrol Dial Transplant 25:419–426

    Article  Google Scholar 

  3. Fricker LD (2020) Proteosome inhibitor drugs. Annu Rev Pharmacol Toxicol 60:457–476. https://doi.org/10.1146/annurev-pharmtox-010919-023603 (Epub 2019 Sep 3)

    Article  CAS  PubMed  Google Scholar 

  4. Siegel, D.S., Martin, T., Wang, M., Vij, R., Jakubowiak, A.J., Lonial, S., Trudel, S., Kukreti, V., Bahlis, N., Alsina, M., Chanan-Khan, A., Buadi, F., Reu, F.J., Somlo, G., Zonder, J., Song, K., Stewart, A.K., Stadtmauer, E., Kunkel, L., Wear, S., Wong, A.F., Orlowski, R.Z., Jagannath, S. (2012). A phase 2 study of single-agent carfilzomib (PX-171–003-A1) in patients with relapsed and refractory multiple myeloma. Blood. 120(14), 2817–25. Doi: https://doi.org/10.1182/blood-2012-05-425934. Epub 2012 Jul 25. PMID: 22833546; PMCID: PMC4123387.

  5. Hájek, R., Masszi, T., Petrucci, M.T., Palumbo, A., Rosiñol, L., Nagler, A., Yong, K.L., Oriol, A., Minarik, J., Pour, L., Dimopoulos, M.A., Maisnar, V., Rossi, D., Kasparu, H., Van Droogenbroeck, J., Yehuda, D.B., Hardan, I., Jenner, M., Calbecka, M., Dávid, M., de la Rubia, J., Drach, J., Gasztonyi, Z., Górnik, S., Leleu, X., Munder, M., Offidani, M., Zojer, N., Rajangam, K., Chang, Y.L., San-Miguel, J.F., Ludwig, H. (2017). A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS). Leukemia. 31(1), 107–114. Doi: https://doi.org/10.1038/leu.2016.176. Epub 2016 Jun 24. PMID: 27416912; PMCID: PMC5220126.

  6. Yui JC, Van Keer J, Weiss BM, Waxman AJ, Palmer MB, D’Agati VD, Kastritis E, Dimopoulos MA, Vij R, Bansal D, Dingli D, Nasr SH, Leung N (2016) Proteasome inhibitor associated thrombotic microangiopathy. Am J Hematol 91(9):E348–E352. https://doi.org/10.1002/ajh.24447 (Epub 2016 Jul 4 PMID: 27286661)

    Article  CAS  PubMed  Google Scholar 

  7. Ball S, Behera TR, Anwer F, Chakraborty R (2020) Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials. Ann Hematol 99(6):1265–1271. https://doi.org/10.1007/s00277-020-04062-x (Epub 2020 May 7 PMID: 32382772)

    Article  CAS  PubMed  Google Scholar 

  8. Liberman V, D’Agati VD, Masani NN, Drakakis J, Mattana J (2016) Acute Tubular Necrosis in a Patient With Myeloma Treated With Carfilzomib. Kidney Int Rep 1(2):89–92. https://doi.org/10.1016/j.ekir.2016.06.002.PMID:29142917;PMCID:PMC5678606

    Article  PubMed  PubMed Central  Google Scholar 

  9. Fotiou D, Roussou M, Gakiopoulou C, Psimenou E, Gavriatopoulou M, Migkou M, Kanellias N, Dialoupi I, Eleutherakis-Papaiakovou E, Giannouli S, Delavinia C, Efstathiou K, Kontogiannis S, Terpos E, Dimopoulos MA, Kastritis E (2020) Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients. Blood Cancer J 10(11):109. https://doi.org/10.1038/s41408-020-00381-4.PMID:33149167;PMCID:PMC7642386

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

    Domenico Giannese & Adamasco Cupisti

  2. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

    Angelo Giovanni Bonadio

  3. Department of Clinical and Experimental Medicine, Hematology Unit, University of Pisa, Pisa, Italy

    Maria Lavinia Del Giudice & Gabriele Buda

Authors
  1. Domenico Giannese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelo Giovanni Bonadio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Lavinia Del Giudice
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adamasco Cupisti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriele Buda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Giannese.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest.

Ethical statement

The informed consent was obtained from the patient for anonymous use of renal biopsy images and data.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giannese, D., Bonadio, A.G., Del Giudice, M.L. et al. Carfilzomib-related glomerular and tubular injury in a patient with Multiple Myeloma. J Nephrol 35, 2131–2134 (2022). https://doi.org/10.1007/s40620-022-01367-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-022-01367-0

Keywords

Search

Navigation